Back to search

Article

Optimizing Pancreatic Cancer Therapy: The Promise of Immune Stimulatory Oncolytic Viruses

2024-08-29

Abstract excerpt

Pancreatic cancer presents formidable challenges due to rapid progression and resistance to conventional treatments. Oncolytic viruses (OVs) selectively infect cancer cells and cause cancer cells to lyse, releasing molecules that can be identified by the host’s immune system. Moreover, OV can carry immune-stimulatory payloads such as interleukin-12 which when delivered locally can enhance immune system-media...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1d6c522d-74f2-51cf-bdbd-41ab44906657
DOI
10.20944/preprints202408.2113.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Optimizing Pancreatic Cancer Therapy: The Promise of Immune Stimulatory Oncolytic VirusesDOI 10.20944/preprints202408.2113.v1
Select a neighboring publication to make it the new centre.